The Market for Rx to OTC Switches

30-Jul-2011 | News-Press Release

Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of the last decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's Market for Rx to OTC Switches, we take a look at recent swtiches, products that may switch in the future, and categories that can benefit most from an OTC product.
 The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.
 All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.
 As part of its coverage, this report includes
 Current Market for Rx to OTC across major categories
 Past Results of OTC Switches
 Products Most Likely to Switch to OTC
 Assessment of the Economic Situation
 The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available:
 Allergy, Cough, Cold, and Sinus Products
 Analgesics, NSAIDs, and Pain Treatments
 Gastrointestinal Drugs
 Oral Care
 Smoking Cessation
 Other Drugs, including:
 Dental Rinses and Fluorides
 Hair Growth Products
 Rectal Ointments
 Sleep Aids
 Weight Management
 Hormone Replacement
For more information kindly visit :
 Related Reports
CytRx Corporation-Deals & Alliances Report
 Hemispherx Biopharma Inc-Deals & Alliances Report

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment